Synthesis and In-Vitro Antimycobacterial Evaluation of 4-Arylidene-2-Phenyl-6-(Aryl)-4,5-Dihydropyridazin-3(2H)-One Derivatives

[1]  Anita Singh,et al.  Studies on new substituted pyridazinones: synthesis and biological evaluation , 2018, Brazilian Journal of Pharmaceutical Sciences.

[2]  Alimuddin Zumla,et al.  Classifying new anti-tuberculosis drugs: rationale and future perspectives. , 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[3]  A. El-Sayed,et al.  Synthesis of Some New Pyridazine Derivatives for Anti-HAV Evaluation , 2017, Molecules.

[4]  M. Akhter,et al.  The therapeutic journey of pyridazinone. , 2016, European journal of medicinal chemistry.

[5]  A. Benomar,et al.  Synthesis and antidepressant activity of 5-(benzo[b]furan-2-ylmethyl)-6-methylpyridazin-3(2H)-one derivatives , 2016, Medicinal Chemistry Research.

[6]  Li Hai,et al.  First synthesis of novel 3,3′-bipyridazine derivatives as new potent antihepatocellular carcinoma agents , 2015 .

[7]  Emiri T. Mandeville,et al.  Discovery of a novel 2,3,11,11a-tetrahydro-1H-pyrazino[1,2-b]isoquinoline-1,4(6H)-dione series promoting neurogenesis of human neural progenitor cells. , 2015, Bioorganic & medicinal chemistry letters.

[8]  N. Rad,et al.  A Study on Antitubercular and Antimicrobial Activity of Isoniazid Derivative , 2015 .

[9]  M. Sekine,et al.  Synthesis of peptide nucleic acids containing pyridazine derivatives as cytosine and thymine analogs, and their duplexes with complementary oligodeoxynucleotides. , 2015, Organic letters.

[10]  M. Asif.  The anticancer potential of various substituted pyridazines and related compounds , 2014 .

[11]  P. Gong,et al.  Design, synthesis and structure-activity relationships of novel 4-phenoxyquinoline derivatives containing pyridazinone moiety as potential antitumor agents. , 2014, European journal of medicinal chemistry.

[12]  M. G. D’Oca,et al.  Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids. , 2013, Bioorganic & medicinal chemistry.

[13]  Peng Zhan,et al.  Synthesis and biological evaluation of pyridazine derivatives as novel HIV-1 NNRTIs. , 2013, Bioorganic & medicinal chemistry.

[14]  N. Khalil,et al.  Synthesis and anti-inflammatory activity of novel pyridazine and pyridazinone derivatives as non-ulcerogenic agents , 2012, Archives of pharmacal research.

[15]  P. Yogeeswari,et al.  Synthesis and antimycobacterial activities of some new N-acylhydrazone and thiosemicarbazide derivatives of 6-methyl-4,5-dihydropyridazin-3(2H)-one , 2012, Medicinal Chemistry Research.

[16]  Juan Tan,et al.  Design, synthesis and antiviral activity of novel pyridazines. , 2012, European journal of medicinal chemistry.

[17]  N. Picci,et al.  Synthesis, characterization and in‐vitro antitubercular activity of isoniazid‐gelatin conjugate , 2012, The Journal of pharmacy and pharmacology.

[18]  C. Velázquez-Martínez,et al.  Synthesis and biological evaluation of isoxazolo[4,5-d]pyridazin-4-(5H)-one analogues as potent anti-inflammatory agents. , 2012, Bioorganic & medicinal chemistry.

[19]  D. Adams,et al.  Phosphodiesterase inhibitors. Part 3: Design, synthesis and structure-activity relationships of dual PDE3/4-inhibitory fused bicyclic heteroaromatic-dihydropyridazinones with anti-inflammatory and bronchodilatory activity. , 2012, Bioorganic & medicinal chemistry.

[20]  A. Husain,et al.  Triazole incorporated pyridazinones as a new class of antihypertensive agents: design, synthesis and in vivo screening. , 2011, Bioorganic & medicinal chemistry letters.

[21]  P. Besada,et al.  New pyridazinone derivatives with vasorelaxant and platelet antiaggregatory activities. , 2010, Bioorganic & medicinal chemistry letters.

[22]  I. Mangalagiu,et al.  Synthesis and antituberculosis activity of some new pyridazine derivatives. Part II. , 2010, European journal of medicinal chemistry.

[23]  C. Kaiser,et al.  Synthesis and Antitubercular Activity of Heteroaromatic Isonicotinoyl and 7-Chloro-4-Quinolinyl Hydrazone Derivatives , 2010, TheScientificWorldJournal.

[24]  S. Nisar,et al.  A study of redox properties of hydralazine hydrochloride, an antihypertensive drug , 2010 .

[25]  P. Puccini,et al.  Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: Synthesis and evaluation of their phosphodiesterase 4 inhibitory activity. , 2010, Bioorganic & medicinal chemistry.

[26]  Tejender S. Thakur,et al.  Structure-based design of DevR inhibitor active against nonreplicating Mycobacterium tuberculosis. , 2009, Journal of medicinal chemistry.

[27]  R. Buxton,et al.  New anti-tuberculosis agents amongst known drugs. , 2009, Tuberculosis.

[28]  M. Alam,et al.  Synthesis and blood glucose lowering effect of novel pyridazinone substituted benzenesulfonylurea derivatives. , 2009, European journal of medicinal chemistry.

[29]  M. Lourenço,et al.  Evaluation of anti-tubercular activity of nicotinic and isoniazid analogues , 2007 .

[30]  Yves L Janin,et al.  Antituberculosis drugs: ten years of research. , 2007, Bioorganic & medicinal chemistry.

[31]  M. Cynamon,et al.  Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base. , 2004, The Journal of antimicrobial chemotherapy.

[32]  K. Hornbuckle,et al.  Evaluation of the Characteristics of Safety Withdrawal of Prescription Drugs from Worldwide Pharmaceutical Markets-1960 to 1999 , 2001 .

[33]  J. Sherris,et al.  Medical Microbiology: An Introduction to Infectious Diseases , 1992 .

[34]  A. Biggs.  THE SPECTROPHOTOMETRIC DETECTION OF CANNABIS SATIVA RESIN , 1953, The Journal of pharmacy and pharmacology.

[35]  A. Verma,et al.  Efficient synthesis, anticonvulsant and muscle relaxant activities of new 2-((5-amino-1,3,4-thiadiazol-2-yl)methyl)-6-phenyl-4,5-dihydropyridazin-3(2H)-one derivatives , 2013, Medicinal Chemistry Research.

[36]  K. Abouzid,et al.  Pyridazinone derivatives: design, synthesis, and in vitro vasorelaxant activity. , 2008, Bioorganic & medicinal chemistry.

[37]  M. Cynamon,et al.  In vitro and in vivo activities of acylated derivatives of isoniazid against mycobacterium tuberculosis. , 2003, Drug design and discovery.

[38]  I. Bastian,et al.  Multidrug-resistant Tuberculosis , 2000, Resurgent and Emerging Infectious Diseases.